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DILATED CARDIOMYOPATHY
Cell-Mediated Cytotoxicity in Hearts With Dilated Cardiomyopathy:
Correlation With Interstitial Fibrosis and Foci of Activated
T Lymphocytes
CORNEL BADORFF, MD, MICHEL NOUTSIAS, MD, UWE KU¨HL, PHD,
HEINZ-PETER SCHULTHEISS, MD
Berlin, Germany
Objectives. The purpose of this study was to investigate the
expression of perforin and T-cell intracellular antigen-1, two
crucial components of lymphocyte-mediated cytotoxicity, in endo-
myocardial biopsies from patients with idiopathic dilated cardio-
myopathy.
Background. Previous reports have demonstrated the presence
of myocardial interstitial fibrosis and increased infiltrating lym-
phocytes in patients with dilated cardiomyopathy. However, the
pathogenic significance of these lymphocytic infiltrates remains
unclear.
Methods. Endomyocardial biopsies from 134 patients with
idiopathic dilated cardiomyopathy were histologically and immu-
nohistologically analyzed. Monoclonal antibodies against diverse
T-lymphocyte antigens, perforin and T-cell intracellular antigen-1
were used with the highly sensitive avidin–biotin complex tech-
nique. Positive cells were counted in at least 10 high power fields.
Results. Perforin and T-cell intracellular antigen-1 were immu-
nohistologically detected in all biopsies. Immunoreactivity was
restricted to the cytoplasm and was granular in nature, indicating
specific staining of cytoplasmic granules. Correlations were estab-
lished between the expression of perforin and T-cell intracellular
antigen-1 and the abundance of foci of various T-lymphocyte
subpopulations and, most importantly, the degree of interstitial
fibrosis on routine histologic examination (p 5 0.015).
Conclusions. Cytotoxic activity is clearly present in endomyo-
cardial biopsies from patients with idiopathic dilated cardio-
myopathy. Local activation—that is, focal accumulation of T
lymphocytes—seems to be important for the generation of
lymphocyte-mediated cytotoxicity. The interstitial fibrosis com-
monly seen in dilated cardiomyopathy may be caused by cytotoxic
T-lymphocyte damage to the myocardium.
(J Am Coll Cardiol 1997;29:429–34)
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By definition, idiopathic dilated cardiomyopathy is a heart
muscle disease of unknown etiology. Viral myocarditis has
emerged as being intimately involved in the pathogenesis of
dilated cardiomyopathy (1). Several lines of evidence suggest a
myocardial enteroviral infection as one possible initiating
event in a significant proportion of patients with dilated
cardiomyopathy. The viral infection may trigger an autoreac-
tive immunologic process, resulting from either molecular
mimicry or expression of cardiac neoantigens (2). In addition
to the involvement of the humoral immune system, character-
ized by the generation of autoantibodies directed against
various cardiac antigens, such as the adenine nucleotide trans-
locator (3), the cellular immune system seems to play a key
role in the pathogenesis of dilated cardiomyopathy (4).
Endomyocardial biopsy is often performed as an adjunct in
establishing the diagnosis of dilated cardiomyopathy (5) to rule
out any specific heart muscle disease (6). The incidence of any
effectively treatable specific heart muscle disease may be low
(5), but certain unspecific findings such as myocardial replace-
ment or interstitial fibrosis can be demonstrated in the major-
ity of patients (7). The pathogenesis of this increased fibrous
tissue deposition within the myocardium remains obscure.
Although the histologic diagnosis of acute or borderline
myocarditis, according to the Dallas criteria (8), can only be
made in a minority of patients with dilated cardiomyopathy
(9,10), taking advantage of the more sensitive and specific
immunohistologic approach has demonstrated the presence of
increased myocardial mononuclear cell infiltrates in at least
one-third of the patients with dilated cardiomyopathy (10).
Furthermore, increased expression of major histocompatibility
complex antigens (11) and adhesion molecules (12) suggests an
ongoing (auto-) immunologic reaction in at least some patients
with idiopathic dilated cardiomyopathy. Although several
mechanisms of both humoral and cellular immune-mediated
myocyte injury are conceivable (13), the pathogenic signifi-
cance of myocardial infiltrating lymphocytes in idiopathic
dilated cardiomyopathy is still poorly understood. Further-
more, no data are available to show a direct myocytotoxic effect
of these infiltrating lymphocytes.
Recently, the molecular mechanisms of lymphocyte target
cell killing were elucidated. On target cell recognition, cyto-
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toxic T lymphocytes exocytose preformed cytoplasmic granules
that contain perforin and T-cell intracellular antigen-1 (TIA-1)
(14). Perforin monomers, after release and cleavage by chy-
mases, are ;68-kDa proteins that bind to target cell mem-
branes and subsequently aggregate to form polymeric pore
structures. These pores perturb membrane permeability and
result in osmotic lysis by sodium and water influx (15). The
physiologic importance of perforin-mediated target cell killing
was documented in vitro by the administration of antisense
oligonucleotides (16) and in vivo by the generation of perforin-
deficient mice (17). Both resulted in greatly impaired
lymphocyte-mediated cytotoxicity. In contrast, expression of
perforin, detected with monoclonal antibodies, correlated with
the cytolytic activity of lymphocytes (18). Apart from the direct
lytic effects of perforin, the perforin pores act as a conduit for
other mediators such as TIA-1. T-cell intracellular antigen-1 is
a 15-kDa polyadenylate binding protein that is known to
induce deoxyribonucleic acid (DNA) degradation on entry into
the target cells and triggers FAS-mediated apoptosis of the
target cell (19,20).
In the present study we immunohistologically demonstrated
the expression of perforin and TIA-1 in endomyocardial
biopsies taken from patients with dilated cardiomyopathy and,
in some cases, the direct release of these mediators onto the
surface of cardiomyocytes. Furthermore, correlations with
other immune markers of endomyocardial biopsies were es-
tablished. The hypothesis to be tested was that mononuclear
cellular infiltrates within the myocardium have a cytotoxic
effect on TIA-1 and may cause the interstitial fibrosis com-
monly seen in dilated cardiomyopathy.
Methods
Study group. This study included 134 patients (53 women
and 81 men; mean [6SD] age 48.3 6 12.7 years) with
idiopathic dilated cardiomyopathy. All patients underwent
echocardiography as well as right and left heart catheteriza-
tion. Duration of symptoms was longer than 6 months (range 6
months to 10 years) without any clinical history of previous
viral infection. All patients had a left ventricular diastolic
diameter $6 cm, with diffuse hypokinesia and an ejection
fraction #40% (9). They did not have any evidence of hyper-
tensive, valvular, systemic, ischemic or congenital heart disease
(21).
Multiple endomyocardial biopsies from the right side of the
ventricular septum were performed by way of the right femoral
vein using a CORDIS bioptome (CORDIS, Haan, Germany)
under fluoroscopic guidance.
Cardiac control tissue was taken at autopsy from patients
with no cardiac pathology who had died from noncardiac
causes (6 from trauma; 6 from suicide; 2 other deaths). Most
samples were taken from the right ventricular septum.
Sample preparation. For conventional histologic examina-
tion, two biopsies were fixed in 10% formalin. For immuno-
histologic study, the remaining biopsy specimens were covered
with TissueTec embedding medium (SLEE, Mainz, Germany)
and snap-frozen in methylbutane in liquid nitrogen at 2708C .
For immunohistologic study, biopsy specimens were serially
cut into 5-mm thick sections, and six to nine serial sections were
analyzed for each antibody. Biopsies were examined by two
observers in blinded fashion.
Light microscopy. Specimens were stained with hematoxylin-
eosin according to standard protocols. Active or borderline
myocarditis was a histologic diagnosis according to the Dallas
criteria (8). Active myocarditis required myocyte necrosis with an
adjacent inflammatory infiltrate, whereas borderline myocarditis
was diagnosed when infiltrating mononuclear cells were seen in
the absence of myocyte injury, with or without interstitial or
reparative fibrosis. The degree of fibrosis was semiquantitated
from 0 5 no; 1 5 mild; 2 5 moderate; to 3 5 severe.
Immunohistology. After fixation with acetone for 10 min,
cryosections were incubated with commercially available
monoclonal antibodies against CD3 (pan T cells), CD4 (helper/
inducer T cells), CD8 (suppressor/cytotoxic T cells), UCHL-1
(activated memory T cells) and major histocompatibility com-
plex (MHC) class I and II (DR subtype) antigens, as described
previously (10).
Antihuman perforin monoclonal antibody, as previously
characterized (22), was purchased from T Cell Diagnostics.
Anti-TIA-1 monoclonal antibody (19) was purchased from
Coulter.
For both antibodies, the sensitive avidin–biotin complex
(ABC) procedure (23) was performed using the Vectastain
elite ABC peroxidase kit (Vector). All incubations were per-
formed at room temperature. Briefly, after blockade of endog-
enous peroxidase with hydrogen superoxide (0.3% in
phosphate-buffered saline [PBS]) for 20 min and blockade of
endogenous avidin and biotin binding sites (avidin/biotin
blocking kit, Vector) for 15 min, slides were incubated with the
appropriately diluted primary antibody (antiperforin 1:10, anti-
TIA-1 1:400 in PBS/5% fetal calf serum) for 1 h. Then,
biotinylated antimouse immunoglobulin G was added for 1 h,
and the ABC reagent was subsequently allowed to react for
30 min. Staining was performed using 3-ethyl-9-aminocarbazol
as a chromogen against hematoxylin counterstain. Sections
were finally covered with Kaiser’s glycerol gelatine.
Cells positive for CD3, CD4, CD8, UCHL-1, perforin and
TIA-1 were counted in at least 10 high power fields (HPF)
under 4003 magnification (1 HPF 5 0.28 mm2). Major
histocompatibility complex antigen expression was semiquan-
titated, as previously described (10). The immunohistologic
diagnosis of increased lymphocytic infiltrates was made for a
Abbreviations and Acronyms
ABC 5 avidin–biotin complex
HPF 5 high power field
MHC 5 major histocompatibility complex
PBS 5 phosphate-buffered saline
TIA-1 5 T-cell intracellular antigen-1
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mean lymphocyte cell count $2.0 cells/HPF (;7 cells/mm2)
accompanied by activated lymphocytes or increased MHC
antigen expression (10). A lymphocytic focus within the myo-
cardium was defined as clustering of at least three positively
stained cells. The abundance of foci within a biopsy specimen
was graded as follows: 0 5 no focus in the entire biopsy
specimen; 1 5 focus in at least one high power field; 11 5
foci in at least half of the analyzed high power fields; 111 5
foci in virtually all analyzed high power fields.
In dilated cardiomyopathy, positive staining for perforin
($2.0 positive cells/HPF) and TIA-1 ($1.5 positive cells/HPF)
was defined as the mean value 6 SD. Positive staining for
cell-mediated cytotoxicity was defined as positive staining for
both perforin and TIA-1.
Statistical analysis. Values are expressed as mean 6 SD.
Statistical analyses were performed using the SPSS software
package. The Student t test was used to compare quantitative
data, and the chi-square test was used to compare qualita-
tive data. Pearson’s correlation coefficient was used for quan-
titative data and Spearman’s correlation coefficient for semi-
quantitative data. A probability value ,0.05 was considered
statistically significant.
Results
In control hearts, no gross cardiac pathology and low
lymphocyte counts were observed (#1.5 CD31 cells/HPF).
Perforin and TIA-1 immunoreactivity was detected in the
majority of specimens (85%), but their expression was low
(0.83 6 0.52 cells/HPF and 0.58 6 0.40 cells/HPF, respective-
ly).
In routine hematoxylin-eosin–stained sections from pa-
tients with dilated cardiomyopathy, 6 (4.5%) of the 134 biopsy
specimens had an increased number of interstitial inflamma-
tory cells without myocytolysis, yielding the diagnosis of bor-
derline myocarditis according to the Dallas criteria. Acute
myocarditis was not seen in any of the examined biopsies.
In the patient group, immunohistologic cell marker analysis
of frozen sections, however, revealed a prevalence of 43% (57
of 134 biopsies) of pathologically increased lymphocytic infil-
trates. The mean cell counts for CD31 cells were 3.3 6 2.3
cells/HPF in the positive samples and 1.3 6 0.5 cells/HPF in
the negative samples.
Perforin and TIA-1 were immunohistologically detected in
Figure 1. Photomicrographs of immunostained idiopathic dilated car-
diomyopathic hearts using antiperforin and anti-TIA-1 monoclonal
antibody. A, Characteristic cytoplasmic granular staining pattern of
myocardial infiltrating mononuclear cells with TIA-1 (31,000, reduced
by 58%). B, Spatial distribution of single perforin-positive cells within
the myocardium (3400, reduced by 58%). C, Clustering of perforin-
positive cells in foci as a sign of local cytotoxic cell activation (3600,
reduced by 58%). D, Release of perforin from cytotoxic cells onto the
surface of adjacent cardiomyocytes (31,000, reduced by 58%).
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all dilated cardiomyopathy biopsy specimens. The staining
pattern for both perforin and TIA-1 showed an immunoreac-
tivity that was restricted to the cytoplasm and appeared
granular as well as focal in nature (Fig. 1A). Usually, single
cytotoxic cells were detected in the myocardium (Fig. 1B).
Occasionally, perforin- and TIA-1-positive cells were clustered
together in foci as a sign of local cytotoxic effector-cell
activation (Fig. 1C). In some cases, staining of adjacent
interstitium and myolemma suggested a direct release of
perforin and TIA-1 onto the surface of cardiomyocytes (Fig.
1D). There was a highly significant correlation between the
expression of perforin and TIA-1 (p , 0.0001), indicating the
specificity of both monoclonal antibodies used. The mean cell
count for perforin and TIA-1 was 1.31 cells/HPF and 0.94
cells/HPF, respectively. The corresponding standard deviations
were 0.67 cells/HPF and 0.51 cells/HPF, respectively.
On average, cell counts for perforin (p , 0.01) and TIA-1
(p , 0.02) per HPF were significantly higher in the tissue
specimens taken from patients with dilated cardiomyopathy in
comparison with the control group.
The expression of perforin and TIA-1 did not differ signif-
icantly between immunohistologically positive and negative
dilated cardiomyopathic biopsies (Table 1). Immunoreactivity
of perforin and TIA-1 in the group with cardiomyopathy,
either expressed as cell count per HPF or positively labeled
biopsy, correlated with the abundance of foci of CD31 (pan T)
cells, CD81 (cytotoxic/suppressor T) cells and UCHL-11
(activated memory T) cells (Table 1). Correlations with the
mere cell count for CD3, CD8 and UCHL-1 were of little or no
significance. CD4 (helper/inducer T cell) immunoreactivity
correlated less consistently with the various variables of per-
forin and TIA-1 expression.
Positive staining for cell-mediated cytotoxicity (perforin
$2.0 cells/HPF and TIA-1 $1.5 cells/HPF, defined as mean
value 6 SD) in dilated cardiomyopathy correlated with the
expression of vascular and interstitial MHC class I antigens
(p 5 0.0253, p 5 0.0081), whereas no relation to MHC class II
antigen expression was observed. Furthermore, positive stain-
ing for cell-mediated cytotoxicity furthermore correlated with
the degree of interstitial fibrosis on routine histologic exami-
nation (p 5 0.015).
Discussion
The findings of the present study demonstrate that in-
creased cytotoxic activity—immunohistologically detected as
perforin and TIA-1 expression—is present in endomyocardial
biopsies from patients with dilated cardiomyopathy. There was
a linear relation between local activation, reflected by focal
accumulation of suppressor/cytotoxic and activated memory T
lymphocytes within the myocardium and the degree of cell-
mediated cytotoxicity variables. Positive staining for perforin
and TIA-1 correlated with the vascular and interstitial major
histocompatibility complex class I antigen expression and, most
importantly, with the degree of interstitial fibrosis on routine
histologic study.
Immunologic factors in the pathogenesis of dilated cardio-
myopathy. The pathogenesis of dilated cardiomyopathy,
which is still largely unknown, has been linked to viral myo-
carditis (1). The hypothesis that dilated cardiomyopathy may
be a sequela of viral myocarditis is based on the presence of an
enteroviral genome within the myocardium of a significant
proportion of patients with both myocarditis and dilated
cardiomyopathy (2). Furthermore, although the incidence of
acute myocarditis, according to the DALLAS criteria (8), in
patients with dilated cardiomyopathy varies greatly between
the different studies (6), immunohistologic studies have shown
that pathologically increased lymphocytic infiltrations can be
Table 1. Correlations of the Expression of Perforin and T-Cell Intracellular Antigen With Other Endomyocardial Biopsy Markers From
Patients With Idiopathic Dilated Cardiomyopathy
Perforin1 Cells/HPF
(p/r values)
Perforin1 Biopsy
(p value)
TIA-11 Cells/HPF
(p/r values)
TIA-11 Biopsy
(p value)
Positive Staining
for Cell-Mediated
Cytotoxicity
(p value)
No. of CD31 cells/HPF 0.020/0.206 0.057 0.001/0.276 0.0070 0.211
Foci of CD31 cells 0.034/0.186 0.124 ,0.001/0.331 0.00021 0.0225
No. of CD41 cells/HPF 0.682 0.284 0.534 0.259 0.322
Foci of CD41 cells 0.351 0.436 0.045/0.225 0.01945 0.02063
No. of CD81 cells/HPF 0.121 0.139 0.058 0.103 0.298
Foci of CD81 cells 0.073 0.0116 0.023/0.202 0.00349 0.00007
No. of UCHL-11 cells/HPF 0.036/0.239 0.034 0.008/0.293 0.052 0.004
Foci of UCHL-11 cells 0.493 0.0377 0.616 0.04343 0.00174
MHC class I antigens on vascular endothelium 0.091 0.155 0.031/0.202 0.0382 0.0253
MHC class I antigens on interstitium 0.055 0.276 0.017/0.221 0.008 0.0081
MHC II antigens on vascular endothelium 0.628 0.156 0.387 0.631 0.693
MHC II antigens on interstitium 0.701 0.887 0.071 0.835 0.754
Degree of interstitial fibrosis 0.249 0.388 0.318 0.171 0.01517
Positive immunohistochemistry 0.258 0.647 0.066 0.107 0.263
HPF 5 high power field; MHC 5 major histocompatibility complex; TIA-1 5 T-cell intracellular antigen-1.
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detected in at least one-third of the patients with dilated
cardiomyopathy (10). These findings and the demonstration of
increased expression of MHC antigens (11) and adhesion
molecules (12), both characteristic of lymphocyte activation,
suggest a chronic inflammatory process in dilated cardiomyo-
pathic hearts (12). However, the pathogenic significance of
these myocardial lymphocytic infiltrates remains to be estab-
lished, as there are currently no data on the mechanism of
T-lymphocyte–mediated myocyte injury in dilated cardiomyop-
athy.
Mechanisms of myocyte injury by lymphocytes. Principally,
there are several possible mechanisms of immunomediated
myocyte injury, as reported elsewhere (13). According to the
most widely supported granule–exocytosis model, cytotoxic
effector cells degranulate on target cell recognition and release
cytolytic mediators such as perforin and TIA-1 (14). Perforin
acts by forming large, nonselective ion channels in the target
cell membrane, which results in osmotic cell lysis (15). In
isolated guinea pig ventricular myocytes, perforin induces a
shortening of the action potential duration and a decline in
both the rest potential and action potential amplitude, leading
to myocyte contracture and destruction (24). T-cell intracellu-
lar antigen-1 is known to induce DNA degradation and thus
triggers FAS-mediated apoptosis of the target cell (19,20).
Perforin and myocarditis. In a murine model of Coxsackie
virus B3–induced myocarditis, perforin was found in the cyto-
plasmic granules of heart-infiltrating cells expressing perforin
messenger ribonucleic acid (25). In addition, the release of
perforin directly onto the surface of cardiac myocytes and
circular lesions characteristic of perforin pores in the mem-
brane of cardiomyocytes could be demonstrated by using
immunoelectron microscopy (26). Young et al. (27) extended
these experimental findings to human myocarditis, where they
were able to show perforin expression in endomyocardial
biopsies from seven patients with acute myocarditis. Taken
together, these results suggest an important role for perforin-
mediated myocardial damage in myocarditis. Until now, no
data were available regarding the expression of cytolytic me-
diators and the importance of cell-mediated cytotoxicity in
dilated cardiomyopathy.
Perforin and TIA-1 in dilated cardiomyopathy. To our
knowledge, our findings are the first to show increased expres-
sion of perforin and TIA-1 in endomyocardial biopsies from
patients with idiopathic dilated cardiomyopathy. Our results
confirm and expand the findings by Seko et al. (28), demon-
strating perforin expression in the hearts of four patients with
dilated cardiomyopathy. However, their study neither included
a control group nor quantitated the perforin expression.
Cardiac control tissue taken from patients who had died
from noncardiac causes displayed significantly lower perforin
(p , 0.01) and TIA-1 expression (p , 0.02). Using specific
anti-perforin and anti-TIA-1 monoclonal antibodies (19,22)
and the sensitive ABC technique (23), we were able to
demonstrate perforin and TIA-1 immunoreactivity restricted
to the cytoplasm, often appearing focal and granular in nature.
This characteristic staining pattern is in good agreement with
previous antibody-based studies (18,28,29) and implies specific
staining of cytoplasmic granules. Furthermore, there was a
highly significant correlation between the expression of per-
forin and TIA-1 (p , 0.0001), indicating the specificity of both
antibodies used and the co-expression of these cytolytic medi-
ators. In some cases, we observed staining of the adjacent
interstitium and myolemma, indicating a direct release of
perforin and TIA-1 onto the surface of cardiomyocytes. This
phenomenon, which is also known from experimental and
human myocarditis (26,27), suggests an important role for
cell-mediated cytotoxicity in dilated cardiomyopathic hearts.
Correlations of perforin and TIA-1 with further immune
markers in dilated cardiomyopathic hearts. Myocyte injury
and subsequent necrosis leads to interstitial replacement fibro-
sis, a frequent but nonspecific finding in the myocardium of
patients with dilated cardiomyopathy (7). In our study, positive
staining for cell-mediated cytotoxicity (defined as positive
staining for perforin and TIA-1, based on mean 6 SD)
correlated with the degree of interstitial fibrosis on routine
histologic study (p 5 0.015). Although this observation is not
necessarily indicative of a causal relation, the interstitial fibro-
sis commonly seen in dilated cardiomyopathy may be caused by
cytotoxic T-cell damage to the myocardium. The fact that no
correlation was found between interstitial fibrosis and perforin
or TIA-1 expression alone may be explained by the lower
stringency of positive staining for just one antigen and under-
lines the importance of investigating multiple antigens in
immunologic myocardial cell phenotyping (30). In addition,
other factors, such as fibroblast-activating cytokines like
interferon-gamma, may be important, as they modulate extra-
cellular matrix composition (31).
Apart from structural myocardial damage due to the “lethal
hit” delivery, cytotoxic T-cell–derived perforin (and TIA-1) is
able to cause reversible target cell injury without lysis. This is
associated with a transient decrease in contractility (13). This
“sublethal hit”—invisible on light microscopy—may explain
the often variable clinical course of dilated cardiomyopathy
(32).
In the past, there was considerable controversy as to
whether a biopsy specimen with lymphocytes can be labeled as
myocarditis in the absence of any visible myocyte injury (6).
Indeed, in our study, the immunohistologic diagnosis of in-
creased lymphocytic infiltrates did not correlate with any
variables of cell-mediated cytotoxicity. This finding implies that
the mere presence of immune cells within the myocardium
does not automatically imply a cytotoxic effect on the cardio-
myocytes. However, other mechanisms such as cytokine gen-
eration may be relevant.
Rather, we found significant correlations between the ex-
pression of perforin and TIA-1 and the abundance of foci of
CD31 (pan T) cells, CD81 (cytotoxic/suppressor T) cells and
UCHL-11 (activated memory T) cells. Correlations with the
mere cell count for CD3, CD8 and UCHL-1 were mostly
of little or no significance. These results suggest that local
activation—that is, focal accumulation—of effector cells seems
to be important for the generation of cell-mediated cytotoxicity.
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Positivity for cell-mediated cytotoxicity correlated with the
presence of increased major histocompatibility complex class I
antigen expression on the vascular endothelium and intersti-
tium. This may be of pathogenic relevance because target-cell-
increased MHC class I antigens facilitate the interaction
between cytotoxic effector cells and their target cells (33).
Study limitations. The conclusions that can be drawn from
the present study are somewhat limited, because the study
provides observational data but no definite proof that expres-
sion of perforin and TIA-1 has a functional impact on cardiac
myocytes. Nevertheless, we believe that this first description of
cell-mediated cytotoxicity in idiopathic dilated cardiomyo-
pathic hearts greatly expands the currently poor knowledge
regarding the pathophysiology of this medically important
disease.
We elected to use autopsy specimens from noncardiac
deaths as a control group rather than biopsy specimens from
patients with atypical chest pain or serious arrhythmias. The
rationale was to exclude biopsy specimens from patients with a
patchy myocardial process such as lymphocytic myocarditis,
which was missed owing to sampling errors (34). Therefore, the
role of cell-mediated cytotoxicity in other cardiac diseases
remains to be established.
Conclusions. This study is the first to demonstrate in-
creased expression of perforin and TIA-1 in idiopathic dilated
cardiomyopathic hearts. Correlations with other biopsy mark-
ers of immune activation and the degree of interstitial fibrosis,
as well as the direct release of these cytolytic mediators onto
cardiomyocyte surfaces, suggest a pathogenic role for cell-
mediated cytotoxicity in idiopathic dilated cardiomyopathy.
Dilated cardiomyopathy and myocarditis appear to share com-
mon mechanisms of immune-mediated myocyte injury, which
further substantiates the link between these two clinically
different entities.
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